Adage Capital Partners Gp, L.L.C. Adma Biologics, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$3.47 - $4.61 $1.71 Million - $2.27 Million	493,000 Added 15.06%	3,767,558 $13.5 Million
Q2 2023 Aug 14, 2023	SELL	$3.12 - $4.22 $1.09 Million - $1.48 Million	-350,000 Reduced 9.66%	3,274,558 $12.1 Million
Q1 2023 May 15, 2023	BUY	$3.01 - $3.87 $3.08 Million - $3.96 Million	1,023,558 Added 39.35%	3,624,558 $12 Million
Q4 2022 Feb 14, 2023	BUY	$2.47 - $3.88 $6.42 Million - $10.1 Million	2,601,000 New	2,601,000 $10.1 Million

325

190M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.27B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.